Search Results

An Interview With Marianne Brodmann, MD

This expert from the Medical University of Graz in Austria discusses the optimal treatment protocols for various endovascular diseases at her center.

Global Perspectives on SFA Treatment: Austria

By Marianne Brodmann, MD

Safety in SFA Intervention

By Marianne Brodmann, MD, and John R. Laird Jr, MD

Real-World SFA Decision-Making

By Marianne Brodmann, MD, and William A. Gray, MD

Femoropopliteal Disease: Challenges and Progress

By Marianne Brodmann, MD, and Ehrin J. Armstrong, MD, MSc, MAS, FACC, FSCAI, FSVM

The Angiosome Concept in Clinical Practice

Implications for patient-specific recanalization procedures.

By Marianne Brodmann, MD

Below-the-Knee CTO Crossing Strategies

Insights on process and procedure.

With Luis Mariano Palena, MD, and Marianne Brodmann, MD

Panel Discussion: Exploring the Paclitaxel Safety Signal

Experts discuss considerations in trial design, adjudication, and paths forward.

With Marianne Brodmann, MD; William Gray, MD; Peter A. Schneider, MD; Ramon L. Varcoe, MBBS, MS, FRACS, PhD; and Thomas Zeller, MD, PhD

Vessel Preparation and Plaque Modification of Infrainguinal Lesions

Defining the terms, discussing the data, and reviewing perspectives on current practices.

By Ehrin J. Armstrong, MD, and Marianne Brodmann, MD

Roundtable Discussion: The Challenges of Extreme Femoropopliteal Calcification

Global perspectives on the current landscape for the treatment of extreme calcification.

Moderator: William A. Gray, MD;
Panelists: Marianne Brodmann, MD; Manar Khashram, MBChB, PhD, FRACS; Andrej Schmidt, MD; and Thomas Zeller, MD

Ask the Experts: How Do You Define ‘High Risk for Restenosis'?

With Gary M. Ansel, MD; Herbert D. Aronow, MD, MPH, FACC, FSCAI, FSVM; Marianne Brodmann, MD; Koen Deloose, MD; Andrew Holden, MBChB, FRANZCR, EBIR; John H. Rundback, MD; and Peter A. Schneider, MD

Bioresorbable Scaffolds: Do Recent Study Results Support Revival for Use in the BTK Arteries?

Emerging platforms, recent study results, and progress in the BTK arteries.

By Marianne Brodmann, MD

Panel Discussion: BTK Drug-Coated Balloons: Can They Clear the Hurdle?

Perspectives on the role of DCBs below the knee, current challenges, and considerations for future trials.

With Marianne Brodmann, MD; Edward Choke, MD; and Andrew Holden, MBChB, FRANZCR, EBIR

Ask the Experts: Based on the tibial DCB trials, is there light at the end of the tunnel?

With Thomas Zeller, MD; J.A. Mustapha, MD; and Marianne Brodmann, MD